How Collaboration Builds Better Treatments for Chronic Lymphocytic Leukemia

Seema Bhat, MD, poses the past era of chemoimmunotherapy against the new age of Bruton tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia.

Noting the often deleterious side effects of chemotherapy, Dr Bhat characterizes recent therapeutic advances as the reward of collaboration between researchers and clinicians striving to develop forms of treatment that provide lasting effects with fewer costs.

Medscape © 2023 WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: How Collaboration Builds Better Treatments for Chronic Lymphocytic Leukemia - Medscape - May 30, 2023.